Pilot Projects and Trans-Network Activities Core
Pilot Projects and Trans-Network Activities Core
批准号:
9446709
负责人:
John F. Dipersio
金额:
$25.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2019-08-31
关键词:
Advisory CommitteesAdvocateApplied ResearchAwardBasic ScienceBiological MarkersCancer CenterCancer Therapy Evaluation ProgramClinical TrialsConflict of InterestDevelopmentEarly Therapeutic-Clinical Trials NetworkElectronic MailFosteringFundingGoalsGrantInstitutionLeadershipLifeMalignant NeoplasmsMentorsMissionModelingNewsletterPatientsPhasePilot ProjectsPre-Clinical ModelProcessRecommendationRecruitment ActivityReproducibilityRequest for ApplicationsResearchResearch MethodologyResearch PersonnelResearch Project GrantsReview CommitteeScientistSolid NeoplasmTestingTranslatingTranslational ResearchUnderrepresented MinorityUniversitiesValidationWashingtonWomanWorkanticancer researchbasehuman diseaseinnovationmemberminority investigatorpatient subsetspre-clinicalprogramsresearch and development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Pilot Projects and Trans-Network Activities Core
The goal of the Pilot Projects and Trans-Network Activities Core is to support the development of research
projects using PDX models that will advance the mission of the PDTC and PDXNet. The core will help to foster
collaborative, translational research using well-characterized PDX models that recapitulate human disease.
Projects will expand the scope of translational research and increase the number of investigators committed to
testing CTEP agents using PDX models for developing the preclinical justification needed for Phase I/II clinical
trials. Requests for Application (RFA) for two awards of $50,000 dollars a year will be solicited. One within the
PDTC and one that is open to non-PDXNet members. The goal of these projects will be to support the
translational goals of the PDTC to advance translational research through the use of PDX models or, research
methods to enhance experimental validation and reproducibility across PDTCs. Requests for Applications
(RFA) for PDX based projects will be requested annually. All developmental research project applications will
be reviewed by Pilot Research Program Advisory Committee consisting of scientists (representing basic and
applied science) with expertise in solid tumor cancers, a biostatistician, a patient advocate, and ad hoc
members, as necessary (special expertise, no conflict of interest). This committee will make recommendations
to the PDTC Leadership Committee, which will make final funding decisions.
Relevance
The work proposed will lead to increased utilization of PDXs as models of human disease that can be used as
the preclinical justification for testing CTEP agents in patient sub-populations based on biomarkers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 6- Targeting AML using bispecific and antibody drug conjugates
-
批准号:10615336
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2021
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:10469493
-
项目类别:
-
资助金额:$89.67万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:10001462
-
项目类别:
-
资助金额:$91.49万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:10596338
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:9765193
-
项目类别:
-
资助金额:$88.74万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:10738323
-
项目类别:
-
资助金额:$6.39万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
-
批准号:10246817
-
项目类别:
-
资助金额:$91.46万
-
财政年份:2017
-
负责人:John F. Dipersio
-
依托单位:
RETARGETING AGENTS TO TREAT AML
-
批准号:9061646
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2015
-
负责人:John F. Dipersio
-
依托单位:
RETARGETING AGENTS TO TREAT AML
-
批准号:9267349
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2015
-
负责人:John F. Dipersio
-
依托单位:
RETARGETING AGENTS TO TREAT AML
-
批准号:8864581
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2015
-
负责人:John F. Dipersio
-
依托单位:
Epigenetic Modulation of GvHD and GvL
-
批准号:8595793
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2013
-
负责人:John F. Dipersio
-
依托单位:
Project 6- Targeting AML using bispecific and antibody drug conjugates
-
批准号:10615376
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2013
-
负责人:John F. Dipersio
-
依托单位:
Epigenetic Modulation of GvHD and GvL
-
批准号:9093729
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2013
-
负责人:John F. Dipersio
-
依托单位:
Project 4 - Targeting AML using novel bispecific and antibody-drug conjugates.
-
批准号:10194403
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2013
-
负责人:John F. Dipersio
-
依托单位:
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
-
批准号:8459447
-
项目类别:
-
资助金额:$56.34万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors
-
批准号:8375660
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
-
批准号:8631076
-
项目类别:
-
资助金额:$88.44万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
-
批准号:10618212
-
项目类别:
-
资助金额:$80.19万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
-
批准号:8289787
-
项目类别:
-
资助金额:$10.73万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
-
批准号:9896762
-
项目类别:
-
资助金额:$80.82万
-
财政年份:2012
-
负责人:John F. Dipersio
-
依托单位:
海外基金